We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Bristol-Myers Squibb to Acquire Padlock Therapeutics

News   Mar 24, 2016

 
Bristol-Myers Squibb to Acquire Padlock Therapeutics
 
 
 

RELATED ARTICLES

Portable Ebola Test Brings Quicker Diagnosis to Remote Regions

News

Researchers have created a portable and fast-acting test that can distinguish Ebola infections from other fever-causing infectious diseases such as Lassa fever and malaria in around 30 minutes. Although further testing is required, this could be useful during febrile disease outbreaks.

READ MORE

Maturation Process of Natural Killer Cells Mapped

News

Notch signaling is necessary for the normal development and function of natural killer cells. This could be significant for the natural killer cells’ ability to fight cancer and infections.

READ MORE

Drug Seeks Out Receptors in Sarcoma Cells, Shrinks Tumors

News

A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE